Premium Brands to Boost Indian Cosmetic Industry

LogoOver the past few years, Indian cosmetic industry has been witnessing a steady growth. Increasing consumer awareness due to the efforts of mass media and affordability due to the rising disposable income are the two most prominent key growth drivers of the Indian cosmetic industry. Media has also played a quite significant role in the growth of the industry. All these factors have boosted the cosmetic sales, especially the premium cosmetic market. According to “Indian Cosmetic Sector Forecast to 2015”, the premium cosmetic market is expected to grow at a CAGR of around 20% during 2011-2015.

Government Support Amplifying Bioinformatics Research

LogoBioinformatics market is growing enormously across the globe on back of rising government support for research and development in the sector. The governments of various countries are extending their financial support to the bioinformatics industry. Also, the governments as well as its associations provide huge funding and grants to the domestic bioinformatics companies. In addition to that, the research centers are receiving massive funding for the development of advanced and upgraded therapies which is boosting the growth of Bioinformatics market in the country. Considering the above factors, Global bioinformatics market is anticipated to grow at a CAGR of 18.5% during 2013-2017.

Thailand Witnessing Strong Growth Potential for CCTV Market

LogoDriven by burgeoning demand in the area of city surveillance, transport and power utilities deployment of CCTV cameras in Thailand is on rise. Also, Thai government is investing huge amount on installation of security systems in the country. Therefore, considering all the factors, the CCTV market in Thailand is anticipated to grow at a CAGR of around 21.5% during 2013-2017.

Illumina's Entry to Shake Up the US NIPD Market Landscape

LogoAs per the new research report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight”, the market for non-invasive prenatal diagnostics in US is expanding at a rapid rate, the latest entrant in the market being Illumina. Illumina has acquired Verinata Health for US$ 350 Million. Its entry into the market is expected to drastically modify the market landscape. Even Sequenom, the current leader in the NIPD market space, is dependent on Illumina’s next generation sequencing solutions for performing the tests. Further, two more players are expected to enter the US market in the next 5 years. With the dynamically evolving market landscape, possibilities are immense, making NIPD one of the most attractive markets in the maternal diagnostics sector.

US Cystic Fibrosis Carrier Screening Market Swells to More Than US$ 300 Million

LogoAccording to a new research report by RNCOS entitled, “Genetic Testing Market Outlook to 2017”, more and more would be American parents are opting for cystic fibrosis (CF) carrier screening test to assess the chances of having a baby suffering with cystic fibrosis. The private sector is actively participating in this robust field attracted by the more than 1 Million CF carrier screening tests that are performed each year in the US. With an average reimbursement rate of US$ 200- 400 per test; the US market is estimated to be in excess of US$ 300 Million per year and witness a high digit growth rate in future.

Government Push Towards Financial Inclusion Drives Prepaid Cards

LogoPrepaid cards are rapidly evolving as an easy and convenient way to provide financial assistance to the underserved. While on one hand, consumer to Government (C2G) payments are on rise through prepaid cards that can be swapped at PoS terminals or used for online transactions, on the other hand, numerous Government schemes have propped up to provide financial aid to the poor through better option of prepaid cards which restricts the misuse of money being transferred from the Government authorities to the deserving hands.

Southern Region Leading in Broiler Feed Consumption

LogoThe Indian poultry feed industry, dependent on the sound growth of poultry has a great untapped potential, with southern part of India holding the maximum share of poultry production and consumption. With increase in the total production of broilers in the Southern region of India, the feed consumption is also growing at par. Most of the big feed manufacturers are also concentrating in Southern States of India.

Influenza Vaccine Market to Grow at CAGR of around 9% during 2012-2017

LogoAs per the new research report by RNCOS, “Global Vaccine Market Forecast to 2017”, world is anticipated to witness the production of around 1.3 Billion doses of seasonal influenza vaccines by the end of 2013. Entry of new manufacturers and clearance of new vaccines through trial phases are going to impact the market in a positive manner. Increased awareness of the need for vaccination against influenza, broader recommendations for vaccination and aging populations are fueling the growth in the world market for flu vaccines, which is expected to reach to grow at a CAGR of around 9% during 2012-2017.

Market Constraints Affecting US Personalized WGS Market

LogoRNCOS research report entitled “US Personalized Cancer Genome Sequencing Market”, says that Whole Genome sequencing technology encompasses huge revenue generation and is much more efficient as far as personalized treatment is concerned. Though WGS method is technologically more advanced as there is a huge cost incorporated with it. Few of the private players are consistently charging different prices based on sequencers and tools required for sequencing. It has also become difficult for the patients to bear out of the pocket expenses for such a high priced procedure. The cost of the sequencing will decline in future based on technological up gradation which would impact the acceptance of technique in the market.

Cancer Therapeutics to Witness Boost in Personalized Medicine

LogoAccording to a new research report by RNCOS entitled, “Personalized Medicine Market Analysis”, cancer therapeutics is a major segment of the personalized medicine market. The earlier “one size fits for all” approach, that resulted in unnecessary side effects and increased healthcare expenditure due to multiple and longer hospital visits and therapy sessions, is being done away with and the new, more efficient and targeted regime of personalized medicine is being followed for the treatment of cancer.